A Phase 1b Trial Of Specific Immunotherapy For Recurrent Respiratory Papillomatosis
Funder
National Health and Medical Research Council
Funding Amount
$141,208.00
Summary
This project will determine whether immunisation can be used to effectively treat an existing infection. To date, immunisation has only been used to prevent infection, but there are many chronic infections where intervention might help the body's defences to to a better job and clear the chronic infection. In this study, we will work out whether this approach can be applied to a virus infection ( papillomavirus) which is associated with cancer. We will test immunisation against a chronic and lif ....This project will determine whether immunisation can be used to effectively treat an existing infection. To date, immunisation has only been used to prevent infection, but there are many chronic infections where intervention might help the body's defences to to a better job and clear the chronic infection. In this study, we will work out whether this approach can be applied to a virus infection ( papillomavirus) which is associated with cancer. We will test immunisation against a chronic and lifethreatening disorder in which warts grow in the respirarory tract, as there is currently no satisfactory treatment for this. If the project is successful we may also learn which blood tests are likely to predict the outcome of immunisation to treat infection.Read moreRead less
The Population Impact Of Human Papillomavirus Vaccination On Circulating Genotypes
Funder
National Health and Medical Research Council
Funding Amount
$249,259.00
Summary
Infection with human papillomavirus (HPV) is very common. Persistent infection can cause abnormal changes to cervical cells as found on Pap smears and if untreated, over time can develop into cervical cancer. Recently, a vaccine was introduced in Australia for women aged 12-26. To monitor the effectiveness of this vaccine, young women aged 18-22 will be asked to self-collect a sample for HPV detection which will determine if HPV types targeted by vaccine are reducing in prevalence.
Aurora A As A Novel Therapeutic Target For HPV-driven Cancers.
Funder
National Health and Medical Research Council
Funding Amount
$762,328.00
Summary
Cervical cancer is caused by a virus and current treatments have not improved for many years. We have performed a screen and identified new drug targets and here we will examine one of these using a drug that has perviously been developed for other cancers. Our preliminary data shows cervical cancer is highly sensitive to this drug and there are few side-effects. We will examine how it works and if it results in permanent protection from new cancers.
We will work with Coridon Pty Ltd to optimize the practical administration of a vaccine designed to cure people already infected with cancer-promoting papilloma viruses.
Human Papillomavirus Infection In Gay Australian Men: Natural History Of The Serological Response And The Relationship Between Seropositivity, Risk Factors And Anal Disease
Funder
National Health and Medical Research Council
Funding Amount
$185,822.00
Summary
Anal cancer rates are increasing globally. Gay men are 20 times more likely than other men to develop anal cancer and for those people living with HIV, the risk is even higher. Human papillomaviruses (HPV) have been shown to cause anal cancer. This research explores the natural history of anal HPV infection and the relationship between HPV infection and anal cancer. These results will potentially inform the development of guidelines for an anal cancer screening program for gay Australian men.
Infectious And Lifestyle Determinants Of Non-melanoma Skin Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$983,711.00
Summary
Basal and squamous cell skin cancers are the leading cancers in Australia, with about 2% of the population developing them each year. As well as sun exposure, a number of other factors have been thought to effect these cancers. This study will examine if factors such as smoking, alcohol consumption and infection with certain skin related human papillomaviruses also increase their risk. Even a small effect may make a big difference when it comes to preventing these common cancers.
Epidemiology Of Human Papillomavirus (Hpv), Ultraviolet (UV) Radiation In Relation To Non-Melanoma Skin Cancer
Funder
National Health and Medical Research Council
Funding Amount
$300,000.00
Summary
Queensland epidemiologist, Professor Adele Green is the winner of an Australian-European Union medical research grant that she will use to investigate prevention of skin cancer. The prestigious NHMRC grant is intended to support Australian researchers involved in European collaboration, which will benefit the Australian community. Professor Green and her research group will use the grant to participate in a large consortium led by Dr Jan Nico Bouwes Bavinck from Leiden in the Netherlands, with t ....Queensland epidemiologist, Professor Adele Green is the winner of an Australian-European Union medical research grant that she will use to investigate prevention of skin cancer. The prestigious NHMRC grant is intended to support Australian researchers involved in European collaboration, which will benefit the Australian community. Professor Green and her research group will use the grant to participate in a large consortium led by Dr Jan Nico Bouwes Bavinck from Leiden in the Netherlands, with teams of researchers based in Germany, England, Italy and France. The work of the consortium will focus on finding out whether Human Papilloma Virus plays a role in causing skin cancer. Professor Green and her team are working to discover the relationship between Human Papilloma Virus, which is a common virus of the skin and the commonest types of skin cancer. If the papilloma virus is found to cause skin cancer, this will open up new avenues for prevention. Although Australia is a world hot-spot for skin cancer, the disease is of concern to Europeans because it is the most common form of cancer in white-skinned people.Read moreRead less
Anogenital Human Papillomavirus Infection And Its Outcomes In Men
Funder
National Health and Medical Research Council
Funding Amount
$333,433.00
Summary
Anal human papillomavirus (HPV) infection is common in homosexual men. Low risk types cause anal warts and high risk types of HPV cause anal cancer. This study will determine incidence and risk factors for HPV infection in a cohort of young homosexual men, the association of anal warts treatment with HIV risk, and the specific association of HPV subtypes with anal cancer. The findings of this research will help delineate the potential benefits of HPV vaccination in this population.
Prevalence Of Genital HPV Infection In Males Following Introduction Of Universal Male HPV Vaccination
Funder
National Health and Medical Research Council
Funding Amount
$320,891.00
Summary
As Australia is the first and only country to implement a free universal school based male human papillomavirus (HPV) vaccination program (in 2013), this project has the unique opportunity to be first to study to assess the effectiveness of the male HPV vaccination program in Australia by measuring a change in the prevalence of HPV among young (aged 17-20) heterosexual and homosexual men following the implementation of the vaccination program.